Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Growth Opportunities are Expected to Drive the Veterinary Active Pharmaceutical Ingredients Manufacturing Market’s CAGR Through 2034?
The market for manufacturing veterinary active pharmaceutical ingredients has seen substantial expansion in the past few years. The market is poised to grow from $7.46 billion in 2024 to about $8.05 billion in 2025, demonstrating an impressive compound annual growth rate (CAGR) of 7.9%. The unprecedented growth observed in the historical period can be linked to factors such as an increase in pet adoption, stringent regulatory norms, heightened attention to animal nutrition, investments in R&D, and overall global economic expansion.
In the coming years, the market for veterinary active pharmaceutical ingredients is predicted to expand significantly. It is projected to reach a value of $11.19 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. This upswing during the forecast period is anticipated due to progress in customized veterinary medication, market extension and globalization, emphasis on regulatory adherence, increasing significance of animal welfare, advancements in drug delivery systems, and a higher demand for nutraceuticals. The major market trends to observe during the forecast period encompass technological progress in manufacturing methods, a rising trend in the outsourcing of API manufacturing, a shift towards biotechnology-based APIs, the automation and digitalization of manufacturing, and the international expansion of the veterinary API market.
What Are the Primary Drivers Supporting the Growth of the veterinary active pharmaceutical ingredients manufacturing Market?
The surge in pet adoption is expected to drive the growth of the veterinary active pharmaceutical ingredients manufacturing market forward. Individuals who own or adopt a pet are often responsible for providing them with essential health services, inevitably increasing the demand for veterinary drugs. Animal Medicines Australia, a non-governmental organization based in Australia, reported a significant rise in pet ownership in 2022. With the number of pet owners reaching 28,730.8 in 2022, this was a significant increase from 39% in 2021. This 24% increase showcases a positive trend in pet adoption and investment in their care. The continued rise in pet ownership in Australian homes emphasizes the growing appeal of pets. Consequently, the escalating number of pet owners is fueling the growth of the veterinary active pharmaceutical ingredients manufacturing market.
Explore Comprehensive Insights Into The Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
What Are the Leading Industry Players Dominating the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are:
• Alivira Animal Health Limited_x000D_
• Excel Industries Limited_x000D_
• Ofichem Group B.V._x000D_
• Jiangsu Lingyun Pharmaceutical Co. Ltd._x000D_
• SUANFARMA S.A._x000D_
What Are the Latest Trends Leading to Disruption in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
Product innovation is emerging as a notable trend in the marketplace for veterinary active pharmaceutical ingredients. The major contenders in this market are tapping into innovative offerings to keep their market positions secure. For instance, Zoetis Inc., a pharmaceutical brand based in the U.S. that caters to pets and livestock, got the nod from the US FDA in January 2022 for Solensia (frunevetmab injection), a treatment for pain caused by osteoarthritis (OA) in cats. Solensia, being the sole injectable monoclonal antibody treatment for feline OA pain to be granted approval in the United States, operates by neutralizing nerve growth factor (NGF), a prominent contributor to pain in osteoarthritis conditions.
Secure Your Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Now for Fast and Efficient Delivery!
What Are the Core Categories and Segments in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Driving Demand and Growth?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors
Which Regions Are Significant to the Growth of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Classified and Defined in Market Analysis?
Veterinary active pharmaceutical Ingredients (APIs) manufacturing refers to the process of producing chemical compounds that are biologically active and used in the formulation of veterinary medicines. These APIs are essential for treating diseases and managing health in animals, including livestock and pets. The manufacturing process ensures the quality, safety, and efficacy of the medications that improve animal welfare and health outcomes.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Patient Monitoring Equipment Global Market Report 2024
Veterinary Diagnostic Equipment Global Market Report 2024
Veterinary Antibiotics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
